Early correction of NMDAR function improves autistic-like social behaviors in adult Shank2−/− mice
暂无分享,去创建一个
Seungjoon | Yeonseung Chung | B. Kaang | T. Boeckers | Eunjoon Kim | H. Won | Hyojin Kang | Won Mah | Doyoun Kim | S. Um | Hyun Kim | Yong-hui Jiang | Changuk Chung | Woohyun Kim | Hwajin Jung | Eunee Lee | Jiseok Lee | Taesun Yoo | Seungmin Ha | Seojung Mo | Y. Kwon | Haidun | Yan | Ye-Eun Yoo | Dongwon Lee | Lee | J. Kim | Ryunhee Kim | Hyosang Kim | Lara | Duffney | Jin Yong Kim | -. Chae | Seok-Rhin Lim | Jihye Kim
[1] M. Kas,et al. Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models , 2018, Front. Mol. Neurosci..
[2] Eunjoon Kim,et al. Cell-Type-Specific Shank2 Deletion in Mice Leads to Differential Synaptic and Behavioral Phenotypes , 2018, The Journal of Neuroscience.
[3] C. Verpelli,et al. SHANK genes in autism: Defining therapeutic targets , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[4] Henry H Yin,et al. Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers. , 2017, JCI insight.
[5] Shireene Kalbassi,et al. Male and Female Mice Lacking Neuroligin-3 Modify the Behavior of Their Wild-Type Littermates , 2017, eNeuro.
[6] H. Hirase,et al. Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice , 2017, Science Advances.
[7] Eunjoon Kim,et al. Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders , 2017, Biological Psychiatry.
[8] Masaaki Sato,et al. Hippocampus-Dependent Goal Localization by Head-Fixed Mice in Virtual Reality , 2017, eNeuro.
[9] G. Feng,et al. SHANK proteins: roles at the synapse and in autism spectrum disorder , 2017, Nature Reviews Neuroscience.
[10] Min Goo Lee,et al. Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice , 2017, Neuropharmacology.
[11] Yong Ho Kim,et al. A critical role of spinal Shank2 proteins in NMDA-induced pain hypersensitivity , 2017, Molecular pain.
[12] Dongwon Lee,et al. Cerebellar Shank2 Regulates Excitatory Synapse Density, Motor Coordination, and Specific Repetitive and Anxiety-Like Behaviors , 2016, The Journal of Neuroscience.
[13] Martijn Schonewille,et al. Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice , 2016, Nature Communications.
[14] T. Bourgeron,et al. Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication , 2016, Journal of visualized experiments : JoVE.
[15] M. Zhuo,et al. Reduced acute nociception and chronic pain in Shank2−/− mice , 2016, Molecular pain.
[16] D. Geschwind,et al. Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.
[17] Zhong Xuan,et al. Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4‐9 Deletion Mouse Model of Autism , 2016, Autism research : official journal of the International Society for Autism Research.
[18] K. Misura,et al. Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness , 2016, Molecular Psychiatry.
[19] Neville E. Sanjana,et al. Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects , 2016, Neuron.
[20] C. Verpelli,et al. Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders , 2015, Journal of neurochemistry.
[21] K. Roche,et al. Dynamic Regulation of N-Methyl-d-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by Posttranslational Modifications* , 2015, The Journal of Biological Chemistry.
[22] Guoping Feng,et al. Modeling psychiatric disorders for developing effective treatments , 2015, Nature Medicine.
[23] T. Bourgeron. From the genetic architecture to synaptic plasticity in autism spectrum disorder , 2015, Nature Reviews Neuroscience.
[24] J. Costas. The role of SHANK2 rare variants in schizophrenia susceptibility , 2015, Molecular Psychiatry.
[25] M. Rietschel,et al. Rare SHANK2 variants in schizophrenia , 2015, Molecular Psychiatry.
[26] S. Nelson,et al. Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders , 2015, Neuron.
[27] C. Powell,et al. Neuroligin 1 modulates striatal glutamatergic neurotransmission in a pathway and NMDAR subunit-specific manner , 2015, Front. Synaptic Neurosci..
[28] R. Huganir,et al. Glutamate synapses in human cognitive disorders. , 2015, Annual review of neuroscience.
[29] J. Crawley,et al. In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages , 2015, Physiology & Behavior.
[30] M. Schmeisser. Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. , 2015, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[31] C. Powell,et al. Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits , 2015, The Journal of Neuroscience.
[32] Yuji Kajiwara,et al. Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators. , 2015, Cell reports.
[33] Eunjoon Kim,et al. Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors , 2015, Front. Mol. Neurosci..
[34] Eunjoon Kim,et al. Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation , 2015, Nature Communications.
[35] G. Rumbaugh,et al. Syngap1 Haploinsufficiency Damages a Postnatal Critical Period of Pyramidal Cell Structural Maturation Linked to Cortical Circuit Assembly , 2015, Biological Psychiatry.
[36] Eunjoon Kim,et al. NMDA receptor dysfunction in autism spectrum disorders. , 2015, Current opinion in pharmacology.
[37] M. Jung,et al. Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression , 2015, Nature Neuroscience.
[38] Elodie Ey,et al. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments , 2014, PLoS genetics.
[39] S. Birnbaum,et al. Autism‐Related Neuroligin‐3 Mutation Alters Social Behavior and Spatial Learning , 2014, Autism research : official journal of the International Society for Autism Research.
[40] S. Chou,et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality , 2014, Nature Neuroscience.
[41] T. Bourgeron,et al. Neurobiology of autism gene products: towards pathogenesis and drug targets , 2014, Psychopharmacology.
[42] K. Tye,et al. Amygdala Inputs to the Ventral Hippocampus Bidirectionally Modulate Social Behavior , 2014, The Journal of Neuroscience.
[43] G. Rosenberger,et al. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci , 2013, Clinical genetics.
[44] P. Worley,et al. Loss of Predominant Shank3 Isoforms Results in Hippocampus-Dependent Impairments in Behavior and Synaptic Transmission , 2013, The Journal of Neuroscience.
[45] Elodie Ey,et al. The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations , 2013, Behavioural Brain Research.
[46] Sharmila Banerjee-Basu,et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.
[47] Zhen Yan,et al. Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism , 2013, The Journal of Neuroscience.
[48] Chang Soon Choi,et al. Pax6-Dependent Cortical Glutamatergic Neuronal Differentiation Regulates Autism-Like Behavior in Prenatally Valproic Acid-Exposed Rat Offspring , 2013, Molecular Neurobiology.
[49] Qiang Zhou,et al. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.
[50] M. Ehlers,et al. Modeling Autism by SHANK Gene Mutations in Mice , 2013, Neuron.
[51] R. Nicoll,et al. Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. , 2013, Cell reports.
[52] M. Bennett,et al. Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism , 2013, Proceedings of the National Academy of Sciences.
[53] M. Till,et al. Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations , 2013, Journal of Medical Genetics.
[54] John Wei,et al. A Discovery Resource of Rare Copy Number Variations in Individuals with Autism Spectrum Disorder , 2012, G3: Genes | Genomes | Genetics.
[55] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[56] Gavin Rumbaugh,et al. Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.
[57] Min Goo Lee,et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function , 2012, Nature.
[58] Anne-Marie Le Sourd,et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.
[59] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[60] Mark F Bear,et al. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. , 2012, Cold Spring Harbor perspectives in biology.
[61] Elodie Ey,et al. Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders , 2012, PLoS genetics.
[62] S. Scherer,et al. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology , 2011, Human molecular genetics.
[63] M. Sheng,et al. The postsynaptic organization of synapses. , 2011, Cold Spring Harbor perspectives in biology.
[64] Hailan Hu,et al. Medial Prefrontal Cortex Bidirectional Control of Social Hierarchy by Synaptic Efficacy in , 2011 .
[65] Lief E. Fenno,et al. Neocortical excitation/inhibition balance in information processing and social dysfunction , 2011, Nature.
[66] J. Silverman,et al. Automated Three‐Chambered Social Approach Task for Mice , 2011, Current protocols in neuroscience.
[67] Alcino J. Silva,et al. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. , 2011, Trends in molecular medicine.
[68] Mark J. Harris,et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication , 2010, Molecular autism.
[69] R. Giorda,et al. Olfactory Receptor-Related Duplicons Mediate a Microdeletion at 11q13.2q13.4 Associated with a Syndromic Phenotype , 2010, Molecular Syndromology.
[70] J. Isaac,et al. Casein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors , 2010, Neuron.
[71] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[72] C. Lord,et al. Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.
[73] T. Südhof,et al. Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior , 2010, The Journal of Neuroscience.
[74] Huilin Li,et al. The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure , 2009, Cell.
[75] T. Südhof. Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.
[76] Jill P. Mesirov,et al. GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..
[77] Toshiyuki Someya,et al. Altered Chemical Metabolites in the Amygdala-Hippocampus Region Contribute to Autistic Symptoms of Autism Spectrum Disorders , 2007, Biological Psychiatry.
[78] Henry Markram,et al. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid , 2007, Proceedings of the National Academy of Sciences.
[79] C. Hoogenraad,et al. The postsynaptic architecture of excitatory synapses: a more quantitative view. , 2007, Annual review of biochemistry.
[80] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[81] Kai Chang,et al. The Synaptic Localization of NR2B-Containing NMDA Receptors Is Controlled by Interactions with PDZ Proteins and AP-2 , 2005, Neuron.
[82] W. Gan,et al. Development of Long-Term Dendritic Spine Stability in Diverse Regions of Cerebral Cortex , 2005, Neuron.
[83] D. Amaral,et al. The Amygdala Is Enlarged in Children But Not Adolescents with Autism; the Hippocampus Is Enlarged at All Ages , 2004, The Journal of Neuroscience.
[84] K. Roche,et al. Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression , 2003, Neuropharmacology.
[85] M. Ehlers,et al. An NMDA Receptor ER Retention Signal Regulated by Phosphorylation and Alternative Splicing , 2001, The Journal of Neuroscience.
[86] Thomas R. Insel,et al. Social amnesia in mice lacking the oxytocin gene , 2000, Nature Genetics.
[87] P. Worley,et al. Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.